For the safety of our patients and staff, we have updated our visitor policy, effective December 27. This includes important information about COVID-19 vaccination or testing for some visitors. Read the latest information for visitors.
Drugging the Undruggable: How to Directly Target Mutant K-Ras
This program is for the research community.
Date & Time(s)
Memorial Sloan Kettering Cancer Center
Zuckerman Research Center
417 East 68th Street
New York, NY 10065
Kevan Shokat, PhD
Professor and Chair, Cellular & Molecular Pharmacology
University of California, San Francisco
Department of Chemistry
University of California, Berkeley
Investigator, Howard Hughes Medical Institute